NEW: Warhound, a Texas defense-tech startup backed by Anduril founder Palmer Luckey and Colossal Biosciences CEO Ben Lamm, has emerged from stealth with a plan to clone and gene-edit military working dogs. The company raised a $200 million seed round at a $1.2 billion valuation from investors including Sequoia Capital, ARK Invest and In-Q-Tel, the CIA-backed venture arm. It aims to reduce U.S. reliance on Europe, which supplies more than 80% of American military working dogs, fewer than half of which complete training due to health and performance problems. Warhound will clone top-performing Belgian Malinois, German Shepherds and Labradors through Colossal-owned Viagen, and edit out genes linked to career-ending conditions such as hip dysplasia and some cancers, with possible future enhancements like wolf-derived scent genes. Anduril will supply armor and sensor-equipped vests, with its role described as “on top of the dog, not in the dog.” Led by former Pentagon chief data officer David Spirk, the company expects its first puppies in early 2027 and aims to have dogs in service by around 2029. https://techcrunch.com/2026/10/22/ben-lamm-raises-200m-for-warhound-to-engineer-war-dogs-and-arm-them-with-anduril-gear/